Gagnon Advisors’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.25M | Hold |
532,892
| – | – | 6.81% | 7 |
|
|
2025
Q4 | $10M | Buy |
532,892
+3,478
| +0.7% | +$58.3K | 6.37% | 5 |
|
|
2025
Q3 | $7.7M | Buy |
529,414
+75,251
| +17% | +$1.07M | 4.75% | 8 |
|
|
2025
Q2 | $8.87M | Buy |
454,163
+41,288
| +10% | +$734K | 5.96% | 5 |
|
|
2025
Q1 | $7.33M | Hold |
412,875
| – | – | 5.17% | 5 |
|
|
2024
Q4 | $8.84M | Hold |
412,875
| – | – | 5.66% | 5 |
|
|
2024
Q3 | $12.9M | Sell |
412,875
-197,461
| -32% | -$4.91M | 8.33% | 2 |
|
|
2024
Q2 | $9.48M | Hold |
610,336
| – | – | 7.22% | 2 |
|
|
2024
Q1 | $6.46M | Buy |
610,336
+55,485
| +10% | +$555K | 5.61% | 6 |
|
|
2023
Q4 | $6.66M | Hold |
554,851
| – | – | 5.82% | 6 |
|
|
2023
Q3 | $3.88M | Hold |
554,851
| – | – | 3.25% | 16 |
|
|
2023
Q2 | $4.72M | Buy |
554,851
+28,763
| +5% | +$240K | 3.16% | 17 |
|
|
2023
Q1 | $4.81M | Buy |
526,088
+87,681
| +20% | +$1.12M | 3.23% | 16 |
|
|
2022
Q4 | $5M | Buy |
438,407
+102,303
| +30% | +$1.52M | 3.38% | 16 |
|
|
2022
Q3 | $5.72M | Buy |
336,104
+58,757
| +21% | +$1.26M | 3.7% | 15 |
|
|
2022
Q2 | $5.96M | Hold |
277,347
| – | – | 3.61% | 13 |
|
|
2022
Q1 | $10.3M | Hold |
277,347
| – | – | 4.73% | 8 |
|
|
2021
Q4 | $12.6M | Buy |
277,347
+23,357
| +9% | +$1.22M | 5.01% | 7 |
|
|
2021
Q3 | $16.1M | Hold |
253,990
| – | – | 6.38% | 1 |
|
|
2021
Q2 | $23.2M | Sell |
253,990
-90,896
| -26% | -$7.23M | 8.84% | 1 |
|
|
2021
Q1 | $23.5M | Hold |
344,886
| – | – | 9.67% | 1 |
|
|
2020
Q4 | $25M | Hold |
344,886
| – | – | 11.23% | 1 |
|
|
2020
Q3 | $13.1M | Hold |
344,886
| – | – | 8.03% | 2 |
|
|
2020
Q2 | $12.2M | Sell |
344,886
-86,647
| -20% | -$2.47M | 8.79% | 2 |
|
|
2020
Q1 | $9.42M | Buy |
431,533
+137,748
| +47% | +$3.09M | 8.79% | 2 |
|
|
2019
Q4 | $6.34M | Hold |
293,785
| – | – | 3.55% | 15 |
|
|
2019
Q3 | $6.64M | Hold |
293,785
| – | – | 4.12% | 9 |
|
|
2019
Q2 | $10.6M | Sell |
293,785
-71,570
| -20% | -$2.29M | 6.04% | 2 |
|
|
2019
Q1 | $11.5M | Sell |
365,355
-131,300
| -26% | -$3.83M | 6.59% | 1 |
|
|
2018
Q4 | $12.5M | Sell |
496,655
-469,239
| -49% | -$12.1M | 8.78% | 1 |
|
|
2018
Q3 | $27.9M | Hold |
965,894
| – | – | 16.7% | 1 |
|
|
2018
Q2 | $11.8M | Buy |
965,894
+10,136
| +1% | +$116K | 7.48% | 2 |
|
|
2018
Q1 | $7.62M | Hold |
955,758
| – | – | 5.67% | 5 |
|
|
2017
Q4 | $7.01M | Buy |
955,758
+952,222
| +26,929% | +$5.94M | 5.14% | 5 |
|
|
2017
Q3 | $3.54M | Sell |
3,536
-950,736
| -100% | -$2M | 2.68% | 19 |
|
|
2017
Q2 | $1.06M | Buy |
954,272
+1,808
| +0.2% | +$1.92K | 0.91% | 26 |
|
|
2017
Q1 | $1.33M | Hold |
952,464
| – | – | 1.21% | 25 |
|
|
2016
Q4 | $2.57M | Hold |
952,464
| – | – | 2.13% | 19 |
|
|
2016
Q3 | $3.38M | Hold |
952,464
| – | – | 2.67% | 17 |
|
|
2016
Q2 | $4.11M | Buy |
952,464
+275,496
| +41% | +$1.27M | 3.47% | 13 |
|
|
2016
Q1 | $3.36M | Hold |
676,968
| – | – | 2.96% | 17 |
|
|
2015
Q4 | $4.33M | Hold |
676,968
| – | – | 3.21% | 14 |
|
|
2015
Q3 | $2.82M | Buy |
676,968
+66,567
| +11% | +$440K | 2.3% | 20 |
|
|
2015
Q2 | $3.97M | Hold |
610,401
| – | – | 2.72% | 17 |
|
|
2015
Q1 | $3.38M | Buy |
610,401
+281,600
| +86% | +$1.86M | 1.98% | 22 |
|
|
2014
Q4 | $2.38M | Hold |
328,801
| – | – | 1.44% | 23 |
|
|
2014
Q3 | $2.3M | Buy |
+328,801
| New | +$3.16M | 1.42% | 24 |
|
Other funds holding CDNA
AIM
DM
B
VCM
GS
Gagnon Advisors's CDNA Position: Q1 2026 in Review
Gagnon Advisors held its CareDx (CDNA) position steady in Q1 2026 at 532,892 shares worth $9.25M. The position accounts for 6.81% of the portfolio, ranked #7.
Gagnon Advisors first reported a position in CDNA in Q3 2014 and has held it in 47 quarters since. The position peaked at $27.9M in Q3 2018. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.
- Gagnon Advisors held 532,892 shares of CareDx worth $9.25M as of Q1 2026.
- Gagnon Advisors left its CareDx share count unchanged in Q1 2026.
- CareDx made up 6.81% of Gagnon Advisors's portfolio in Q1 2026, its #7 holding.
- Gagnon Advisors first reported a position in CareDx in Q3 2014 and has held it in 47 quarters since.
- Gagnon Advisors's CareDx position peaked at $27.9M in Q3 2018.
- 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.
Based on Gagnon Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.